Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia

被引:11
|
作者
Guardiola, P
Kurre, P
Vlad, A
Cayuela, JM
Espérou, H
Devergie, A
Ribaud, P
Socié, G
Richard, P
Traineau, R
Storb, R
Gluckman, E
机构
[1] Hop St Louis, Serv Greffe Moelle Trefle 3, Bone Marrow Transplant Unit, F-75475 Paris 10, France
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[3] Hop St Louis, INSERM, U462, Paris, France
[4] Hop St Louis, Cent Hematol Lab, Paris, France
[5] Hop St Louis, Blood Bank Dept, Paris, France
关键词
Fanconi anaemia; allogeneic stem cell transplantation; graft-versus-leukaemia effect; acute leukaemia; myelodysplasia;
D O I
10.1046/j.1365-2141.2003.04503.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic transplantation is the only curative treatment for Fanconi anaemia (FA) patients who develop myeloid malignancies. Dose-intensive preparative regimens, to decrease disease recurrence, lead to unacceptable transplant-related toxicity in FA. We report the outcome of three FA patients with such malignancies who underwent transplantation with reduced-intensity preparative regimens. This approach was well tolerated, even as second transplantations, and resulted in complete leukaemic remissions. However, the graft-versus-leukaemia effect was associated with fatal graft-versus-host disease. Even after transplantation, myeloid malignancies remain associated with a poor outcome in FA, and this argues in favour of early intervention when suitable donors are available.
引用
收藏
页码:806 / 809
页数:4
相关论文
共 50 条
  • [1] Role of the graft-versus-leukaemia effect after reduced-intensity conditioning allogeneic stem cell transplantation as treatment for acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of the EBMT
    Baron, F.
    Labopin, M.
    Mohty, M.
    Basara, N.
    Niederwieser, D.
    Milpied, N.
    Cornelissen, J. J.
    Malm, C.
    Vindelov, L.
    Blaise, D.
    Janssen, J. J. W. M.
    Petersen, E.
    Socie, G.
    Rocha, V.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S10 - S10
  • [2] Sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in Fanconi anaemia with myeloid leukaemia or myelodysplastic syndrome
    Talbot, A.
    de Latour, R. Peffault
    Buchbinder, N.
    Vigouroux, S.
    Milpied, N.
    Michallet, M.
    Socie, G.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S154 - S154
  • [3] The role of reduced-intensity allogeneic stem cell transplantation in patients with advanced acute myeloid leukaemia and myelodysplastic syndromes
    Espigado, I.
    Marquez-Malaver, F. J.
    de la Cruz, F.
    Falantes, J.
    Montero, I.
    Parody, R.
    Carmona, M.
    Perez-Hurtado, J. M.
    Urbano-Ispizua, A.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S113 - S113
  • [4] Long-term outcome of patients with acute myeloid leukaemia and myelodysplastic syndrome after reduced-intensity conditioning for allogeneic hematopoietic cell transplantation
    Worel, N.
    Kalhs, P.
    Mitterbauer, M.
    Rabitsch, W.
    Schulenburg, A.
    Woehrer, S.
    Kuzmina, Z.
    Greinix, H. T.
    [J]. ONKOLOGIE, 2012, 35 : 121 - 122
  • [5] Long-term outcome of patients with acute myeloid leukaemia and myelodysplastic syndrome after reduced-intensity conditioning for allogeneic haematopoietic cell transplantation
    Kalhs, P.
    Mitterbauer, M.
    Rabitsch, W.
    Schulenburg, A.
    Woehrer, S.
    Kuzmina, Z.
    Greinix, H. T.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S416 - S417
  • [6] The role of reduced-intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a donor versus no donor comparison
    de Lavallade, H
    Mohty, M
    Ladaique, P
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Blaise, D
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S15 - S15
  • [7] Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplant in HIV-infected patient with acute myeloid leukaemia
    A. Kanellopoulos
    M. Kaparou
    E. Xenou
    S. Paneesha
    B. Kishore
    R. Lovell
    K. Holder
    J. Suhr
    L. Baker
    L. Ryan
    E. Nikolousis
    [J]. Bone Marrow Transplantation, 2018, 53 : 1518 - 1521
  • [8] Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia
    Kanellopoulos, A.
    Kaparou, M.
    Xenou, E.
    Paneesha, S.
    Kishore, B.
    Lovell, R.
    Holder, K.
    Suhr, J.
    Baker, L.
    Ryan, L.
    Nikolousis, E.
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (12) : 1518 - 1521
  • [9] ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IN CHRONIC MYELOID LEUKAEMIA
    Morozova, E., V
    Vlasova, Y., I
    Barabanshikova, M., V
    Afanaseva, K. S.
    Iurovskaia, K. S.
    Gindina, T. L.
    Barchatov, I. M.
    Alyanskiy, A. L.
    Bakin, E. A.
    Bondarenko, S. N.
    Moiseev, I. S.
    Zubarovskaya, L. S.
    Afanasyev, B., V
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04): : 386 - 402
  • [10] Reduced-intensity unrelated cord blood transplantation for adult patients with acute myeloid leukaemia/myelodysplastic syndrome
    Masuoka, K.
    Miyakoshi, S.
    Takagi, S.
    Kato, D.
    Yamamoto, H.
    Matsuhashi, K.
    Seo, S.
    Matsuno, N.
    Uchida, N.
    Wake, A.
    Taniguchi, S.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S39 - S39